개인구독
소속 기관이 없으신 경우, 개인 정기구독을 하시면 저렴하게
논문을 무제한 열람 이용할 수 있어요.
지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2023.6
- 수록면
- 1 - 8 (8page)
- DOI
- 10.17262/KJPH.2023.06.60.1.1
이용수
초록· 키워드
오류제보하기
Objectives: The COVID-19 pandemic that began in 2020 is the largest pandemic since the 1918 influenza pandemic, causing significant loss of life worldwide. To accurately understand and prepare for future pandemics, it is important to have a detailed understanding of the number of COVID-19 cases worldwide, as well as an assessment of the reliability of the reported incidence and mortality data from each country.
Methods: This study compared COVID-19 incidence, mortality, case fatality rates reported by 11 countries with the COVID-19 infection induced antibody seropositivity rates obtained from 15 surveys conducted in those countries.
Results: Based on patient incidence statistics reported by various countries from the start of the pandemic in 2020 up to March 7, 2023, patient incidence and mortality rates are higher in high-income countries and lower in low- and middle-income countries. Conversely, the case fatality rate is lower in high-income countries and higher in low- and middle-income countries. However, it is important to note that these results may be due to different reporting rates in each country. The analysis found that the estimated reporting rates of COVID-19 in low- and middle-income countries were estimated to be between 0.4% and 1.3%, while the estimated reporting rates in high-income countries were estimated to be between 15.1% and 78.5%.
Conclusion: Among the high-income countries, those with a high proportion of patients from 2020 to the end of 2021 who required hospitalization had higher case fatality rates.
Methods: This study compared COVID-19 incidence, mortality, case fatality rates reported by 11 countries with the COVID-19 infection induced antibody seropositivity rates obtained from 15 surveys conducted in those countries.
Results: Based on patient incidence statistics reported by various countries from the start of the pandemic in 2020 up to March 7, 2023, patient incidence and mortality rates are higher in high-income countries and lower in low- and middle-income countries. Conversely, the case fatality rate is lower in high-income countries and higher in low- and middle-income countries. However, it is important to note that these results may be due to different reporting rates in each country. The analysis found that the estimated reporting rates of COVID-19 in low- and middle-income countries were estimated to be between 0.4% and 1.3%, while the estimated reporting rates in high-income countries were estimated to be between 15.1% and 78.5%.
Conclusion: Among the high-income countries, those with a high proportion of patients from 2020 to the end of 2021 who required hospitalization had higher case fatality rates.
목차
Abstract
Introduction
Methods
Results
Discussion
Conclusion
References
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Social and Policy Determinants of COVID-19 Infection Across 23 Countries: An Ecological Study
예방의학회지
2022 .03
-
COVID-19 Pandemic Era
대한외과학회 학술대회 초록집
2020 .11
-
Interaction Effects between COVID-19 Outbreak and Community Income Levels on Excess Mortality among Patients Visiting Emergency Departments
Journal of Korean Medical Science
2021 .01
-
Cross-Country Comparison of Case Fatality Rates of COVID-19/SARS-COV-2
Osong Public Health and Research Persptectives
2020 .01
-
Analysis on 54 Mortality Cases of Coronavirus Disease 2019 in the Republic of Korea from January 19 to March 10, 2020
Journal of Korean Medical Science
2020 .01
-
Global variation of COVID-19 mortality rates in the initial phase
Osong Public Health and Research Persptectives
2021 .01
-
Comments on the article "Time-series comparison of COVID-19 case fatality rates across 21 countries with adjustment for multiple covariates"
Osong Public Health and Research Persptectives
2023 .04
-
General guideline in the endoscopy room to avoid air-borne infection during the COVID-19 pandemic
Clinical Endoscopy
2022 .09
-
Why Have the Republic of Korea, Taiwan, and Singapore Coped Well with COVID-19 and What Are the Lessons Learned from Their Experiences?
Yonsei Medical Journal
2022 .03
-
Neglected issues related to the COVID-19 pandemic
Osong Public Health and Research Persptectives
2023 .06
-
Epidemiology, Incidence and Mortality of Bladder Cancer and their Relationship with the Development Index in the World
Asian Pacific journal of cancer prevention : APJCP
2016 .01
-
Association between face covering policies and the incidence of coronavirus disease 2019 in European countries
Osong Public Health and Research Persptectives
2023 .02
-
COVID-19
International Neurourology Journal
2020 .01
-
Age-Related Morbidity and Mortality among Patients with COVID-19
Infection and Chemotherapy
2020 .01
-
Scrutiny of COVID-19 response strategies among severely affected European nations
Osong Public Health and Research Persptectives
2021 .08
-
Management of Severe Asthma During the COVID-19 Pandemic in Korea
Allergy, Asthma & Immunology Research
2020 .01
-
Mortality Rate and Outcomes of Omicron Variant Positive Patients with Osteoporotic Fractures: A Retrospective Study
대한골대사학회지
2024 .02
-
COVID-19 팬데믹 종료 후 종합병원 간호사의 심리·사회적 건강에 영향을 미치는 요인
기본간호학회지
2023 .11
-
Impact of the Early COVID-19 Pandemic on Emergency Department Visits of Adult Cancer Patients With Fever or Respiratory Symptoms: A Korean Nationwide Population-Based Study, 2016–2020
Journal of Korean Medical Science
2024 .06
-
Safely navigating kidney transplantation during the COVID-19 pandemic: the Singapore General Hospital’s experience
Clinical Transplantation and Research
2023 .06
이 논문의 저자 정보
이 논문과 함께 이용한 논문
일본군 ‘위안부’ 문제와 책임성
김희강
아세아연구
2010
.09
코로나바이러스감염증-19 대유행이 정신건강에 미치는 영향
박상미
보건교육건강증진학회지
2020
.12
Social and Policy Determinants of COVID-19 Infection Across 23 Countries: An Ecological Study
Kyungsik Kim
,
Young-Do Jeung
,
Jeoungbin Choi
외 2명
예방의학회지
2022
.03
식물 유래 바이오의약품 생산을 위한 진공침윤 공정 기술 개발
김용진
,
박진호
,
안준기
외 4명
한국생산제조학회 학술발표대회 논문집
2022
.12
임상 2상 연구를 위한 코로나19 백신 생산 공정 개발
이주민
,
홍나영
,
박진호
외 6명
한국생산제조학회 학술발표대회 논문집
2022
.12
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-ECN-0101-2023-517-001477665